Author

Julien Dairou

Centre National de la Recherche ScientifiqueORCID 0000-0003-1767-0572Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Neuroscience· 2 Developmental Biology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 4 Organism:mouse· 2 Organism:bacteria (other)· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Assay:metabolomics· 1

Frequent Co-Authors

Alexandra GrussiD· 1 shared Anita BhattacharyyaiD· 1 shared Annie Varrault· 1 shared Arnaud DuchoniD· 1 shared Audrey SolgadiiD· 1 shared Bastien ProstiD· 1 shared Benôıt GirardiD· 1 shared Cedric Barboux· 1 shared

Activity by Year

2019-2026 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 10 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

Alexandra GrussORCID

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

NeurosciencebioRxivPreprintMay 16, 2026

LONG-TERM NEURODEVELOPMENTAL AND COGNITIVE OUTCOMES FOLLOWING PRENATAL INHIBITION OF DYRK1A BY LEUCETTINE L41 IN MOUSE MODELS OF DOWN SYNDROME

Arnaud Duchon, Claire Chevalier, Patrick Gizzi…·Yann Hérault

This study investigates the effects of prenatal DYRK1A inhibition with Leucettine L41 in DS mouse models, showing lasting cognitive and gene expression improvements with model-specific outcomes.

DOI 10.64898/2026.05.13.724917

mouseexperimental assay

𝕏 PostBluesky

MicrobiologybioRxivPreprintApr 7, 2026

The fatty acid synthesis pathway is a checkpoint for lipoteichoic acid synthesis in Staphylococcus aureus

Paprapach Wongdontree, Clara Louche, Julien Dairou…·Jamila Anba‐Mondoloni

This study identifies the fatty acid synthesis pathway as a key regulator of lipoteichoic acid synthesis in Staphylococcus aureus by controlling glycerophosphate availability.

DOI 10.64898/2026.04.06.715823

bacteria (other)metabolomics

𝕏 PostBluesky

Developmental BiologybioRxivPreprintFeb 5, 2026

Leucettinib-21 decreases dosage effects of DYRK1A in human trisomy 21 iPSC-derived neural cells

Nicole R. West, Mattias F. Lindberg, Julien Dairou…·Anita Bhattacharyya

This study shows that Leucettinib-21 reduces DYRK1A activity in human trisomy 21 neural cells, supporting its potential as a therapeutic for Down syndrome.

DOI 10.64898/2026.02.05.704014

humanexperimental assay

𝕏 PostBluesky

NeurosciencebioRxivJan 9, 2019

The mGlu7 receptor provides protective effects against epileptogenesis and epileptic seizures

Benôıt Girard, Pola Tuduri, Maria Paula Moreno…·Federica Bertaso

This study investigates the protective effects of mGlu7 receptor activation against epileptogenesis and seizures using a drug in two mouse models.

27 citations

mouseexperimental assay

𝕏 PostBluesky